StonvexLoading…
StonvexStonvexStonvexCore line items from ALTO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2020 2020-11-30 |
|---|---|---|---|---|
Revenue | $100.00M | $1.21B | $897.02M | $3.20M |
Operating Income | $-61.36M | $40.07M | $9.85M | Not available |
Net Income | $-41.60M | $46.08M | $-15.12M | Not available |
EPS (Diluted) | $-0.60 | $0.61 | $-0.28 | Not available |
Total Assets | $478.32M | $484.95M | $476.82M | Not available |
Total Liabilities | $170.23M | $139.74M | $180.58M | Not available |
Cash & Equivalents | $36.46M | $50.61M | $47.67M | Not available |
Free Cash Flow OCF − CapEx | $-31.70M | $10.44M | $65.10M | Not available |
Shares Outstanding | 75.15M | 72.78M | 72.49M | Not available |